A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Sunny start to Sunday, feeling chilly. Patchy cloud further east, temperatures soon lifting. Fine afternoon
Saturday Evening Weather with Emma
This weekend we swap one area of high pressure for another, with some fronts inbetween. Improving weather through the weekend...